A meta-analysis of 20 studies including 4,843 COVID-19 patients and focusing on the clinical utility of CRP,51 emphasized that high CRP level was associated with a fourfold higher risk of an unfavorable outcome (p<10−3). This evidence concerns the gene CRP and COVID-19.